Back
Vanguard S&P Mid-Cap 400 Index Fund ETF Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison
Buy
70
IVOO
Vanguard S&P Mid-Cap 400 Index Fund ETF
Last Price:
$113.27
Seasonality Move:
6%
Sell
37
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$25.65
Seasonality Move:
0.37%
Buy
70
Vanguard S&P Mid-Cap 400 Index Fund ETF (IVOO)
is a Buy
Is Vanguard S&P Mid-Cap 400 Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard S&P Mid-Cap 400 Index Fund ETF [IVOO] share price is $112.69. The Score for IVOO is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
IVOO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $25.61. The Score for AMPH is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IVOO Stock Price Chart
What is Vanguard S&P Mid-Cap 400 Index Fund ETF's stock price today?
-
The Vanguard S&P Mid-Cap 400 Index Fund ETF share price today is $112.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVOO is experiencing slight selling pressure.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $25.61Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMPH is experiencing slight selling pressure.
IVOO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 55.23 | Buy |
| Chaikin Money Flow: | -10338 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46.26 | Sell |
| Chaikin Money Flow: | -108584 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.65 - 27.27) | Sell |
| Bollinger Bands (100): | (23.82 - 28.88) | Sell |
IVOO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 113.18 | Sell |
| 20-day SMA: | 111.19 | Buy |
| 50-day SMA: | 110.36 | Buy |
| 200-day SMA: | 105.45 | Buy |
| 8-day EMA: | 113.02 | Sell |
| 20-day EMA: | 111.9 | Buy |
| 50-day EMA: | 110.76 | Buy |
| 200-day EMA: | 107.56 | Buy |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.9 | Sell |
| 20-day SMA: | 26.41 | Sell |
| 50-day SMA: | 25.48 | Buy |
| 200-day SMA: | 25.65 | Sell |
| 8-day EMA: | 25.99 | Sell |
| 20-day EMA: | 26.16 | Sell |
| 50-day EMA: | 26.06 | Sell |
| 200-day EMA: | 27.93 | Sell |
Vanguard S&P Mid-Cap 400 Index Fund ETF Earnings Growth & IVOO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.20 per share.
Vanguard S&P Mid-Cap 400 Index Fund ETF Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||